半乳糖凝集素-1与半乳糖凝集素-3作为圆锥角膜前瞻性生物标志物的评估
本研究评估圆锥角膜(KC)患者及体外角膜胶原交联(CXL)处理后半乳糖凝集素(Gal)-1与Gal-3的表达。KC患者结膜上皮细胞Gal-1、Gal-3水平较对照升高,KC角膜基质中角化细胞强烈表达Gal-1,角化细胞内源性Gal-3升高而Gal-1不升高;体外CXL使角化细胞上清Gal-1显著释放(116±18 ng/mL,P<0.05)并降低IL-6、IL-8、MMP-2、MMP-9。作者认为Gal-1与Gal-3是值得关注的新KC生物标志物。
要点
- KC患者结膜上皮细胞Gal-1与Gal-3水平较对照升高。
- KC角膜基质角化细胞强烈表达Gal-1,内源性Gal-3升高而Gal-1不升高。
- 体外CXL使角化细胞上清Gal-1释放达116±18 ng/mL(P<0.05),并降低IL-6、IL-8、MMP-2、MMP-9。
核心结论
- Gal-1与Gal-3因在KC与对照角膜样本中表达模式不同,是值得关注的新KC生物标志物。
- CXL对角化细胞具有免疫抑制作用,表现为细胞因子与MMP释放减少、抗炎蛋白Gal-1表达增加。
研究设计与样本
- 研究采用对照与KC患者的泪液、角膜样本及结膜印迹细胞学标本评估Gal-1与Gal-3表达。
- 原代角化细胞经胶原酶消化从5枚正常或KC人角膜植片的手术切除角膜中分离,在含2%胎牛血清的DMEM/Ham's F12培养基中培养。
- 体外实验设对照与紫外线A光联合0.1%核黄素(CXL)处理30分钟两种条件。
主要发现
- KC患者结膜上皮细胞Gal-1与Gal-3水平较对照升高。
- KC角膜基质中角化细胞强烈表达并释放Gal-1。
- 角化细胞超微结构分析显示KC中内源性Gal-3水平明显升高,而Gal-1未见升高。
- 体外CXL使角化细胞上清Gal-1显著释放(116±18 ng/mL,P<0.05),并降低IL-6、IL-8、MMP-2、MMP-9等炎症生物标志物。
- 角化细胞上清中未检测到Gal-3水平。
关键数值与推荐
- 体外CXL处理后角化细胞上清Gal-1为116±18 ng/mL(P<0.05)。
- 体外CXL处理时间为30分钟,核黄素浓度为0.1%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To evaluate the expression of β-galactoside-binding proteins galectin (Gal)-1 and Gal-3 in patients with keratoconus (KC) and postcorneal collagen cross-linking (CXL) treatment in vitro. METHODS: Tear fluid, cornea samples and conjunctival impression cytology specimens from control and KC patients were used to evaluate Gal-1 and Gal-3 expressions. Primary keratocytes were isolated by collagenase digestion from surgically removed corneas of five normal or KC human corneal buttons and cultured in Dulbecco's modified eagle medium/Ham's F12 medium supplemented with 2% fetal bovine serum. These cells were evaluated under two experimental conditions: control and submitted to the application of ultraviolet A light and riboflavin 0.1% (CXL) for 30 min. RESULTS: Patients with KC displayed increased levels of Gal-1 and Gal-3 in conjunctival epithelial cells compared with control. Furthermore, KC corneas were associated with intense expression of Gal-1 in the stroma, released by keratocytes. Ultrastructural analysis of keratocytes showed a marked increase of endogenous Gal-3 levels, but not Gal-1, in KC. In vitro, CXL induced significant release of Gal-1 in keratocyte supernatants (116±18 ng/mL, P<0.05) and decreased inflammatory biomarkers as interleukin (IL)-6, IL-8, matrix metalloproteinase (MMP)-2 and MMP-9. Gal-3 levels were not detected in the keratocyte supernatants. CONCLUSION: Gal-1 and Gal-3 represent new interesting KC biomarkers as revealed by their different expression patterns in KC and control corneal samples. CXL has an immunosuppressive effect on keratocytes by reducing the release of cytokines and MMPs and increased expression of anti-inflammatory protein Gal-1.
引用
- Andrade FEC, Covre JL, Ramos L, et al. Evaluation of galectin-1 and galectin-3 as prospective biomarkers in keratoconus. Br J Ophthalmol. 2018. PMID: 29439091. doi:10.1136/bjophthalmol-2017-311495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。